Product NDC: | 66993-049 |
Proprietary Name: | Olanzapine |
Non Proprietary Name: | Olanzapine |
Active Ingredient(s): | 7.5 mg/1 & nbsp; Olanzapine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66993-049 |
Labeler Name: | Prasco Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020592 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20111023 |
Package NDC: | 66993-049-05 |
Package Description: | 1 BOTTLE in 1 CARTON (66993-049-05) > 1000 TABLET in 1 BOTTLE |
NDC Code | 66993-049-05 |
Proprietary Name | Olanzapine |
Package Description | 1 BOTTLE in 1 CARTON (66993-049-05) > 1000 TABLET in 1 BOTTLE |
Product NDC | 66993-049 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Olanzapine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20111023 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Prasco Laboratories |
Substance Name | OLANZAPINE |
Strength Number | 7.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Atypical Antipsychotic [EPC] |